This message was sent to ##Email##
|
|
|
|
|
Infection Control Today
Cows are leaving the pasture and entering the field of HIV vaccine research. As outlined in a study published in Nature, lead author Devin Sok, director of antibody discovery and development at the International AIDS Vaccine Initiative, reports the elicitation of powerful, HIV-blocking antibodies in cows in a matter of weeks — a process that usually takes years in humans.
READ MORE
St. Jude Children's Research Hospital via ScienceDaily
Researchers led by St. Jude Children's Research Hospital have identified a genetic variation associated with influenza severity and the supply of killer T cells that help patients fight the infection.
Researchers have discovered an inherited genetic variation that may help identify patients at elevated risk for severe, potentially fatal influenza infections. The scientists have also linked the gene variant to a mechanism that explains the elevated risk and offers clues about the broader anti-viral immune response.
READ MORE
|
Promoted by
|
|
|
|
 |
Elsevier via Medical Xpress
Scientists have found a new way to protect stem cells from harsh inflammation during wound repair. In a study recently published in the journal Cytotherapy, researchers in India discovered that treating mice with a common anti-inflammatory drug called celecoxib promoted stem cell survival and healing when they injected the cells into wounds.
READ MORE
Scientific American
In the days after a heart attack, surviving patients and their loved ones can breathe a sigh of relief that the immediate danger is over — but the scar tissue that forms during the long healing process can inflict lasting damage. Too often it restricts the heart's ability to fill properly between beats, disrupting rhythm and ultimately leading to heart failure. Yet a new possible treatment may help to revitalize an injured ticker.
READ MORE
 |
|
ZeptoMetrix Corporation (ZMC) is an Industry leader and innovator identified with quality, reliable and trusted Products and Services for Infectious Disease Diagnostic Development. From assay conception to launch, our Scientific and Operational Teams provide our Customers with cohesive, inventive and cost effective solutions.
Learn More
|
|
DARK Daily
Hospitals, physicians and medical laboratories recognize the transition from “volume to value” that’s underway in the American healthcare system. Fee-for-service payments for clinical services (regardless of whether they are needed or effective) will soon cease and providers will be increasingly paid on how much value they deliver to patient care.
READ MORE
Health Canal
By blocking an enzyme that affects the cellular microenvironment, it is possible to stop brain tumor cells from growing. This is shown in a new study published in the journal Molecular Cancer Therapeutics by researchers at Uppsala University in collaboration with researchers in Haifa, Israel, and Brisbane, Australia.
READ MORE
|
Promoted by
|
|
|
|
 |
University of Illinois at Urbana-Champaign via Lab Manager
It took two years on a supercomputer to simulate 1.2 microseconds in the life of the HIV capsid, a protein cage that shuttles the HIV virus to the nucleus of a human cell. The 64-million-atom simulation offers new insights into how the virus senses its environment and completes its infective cycle.
READ MORE
|
|
 |
|
LGC Maine Standards offers VALIDATE® HbA1c for Easier Calibration Verification / Linearity Testing.
VALIDATE® HbA1c is a liquid,
easy-to-use kit that tests linearity for % Glycohemoglobin A1c in a human-whole-blood
base matrix. VALIDATE® virtually eliminates dilutions while maximizing reportable
ranges. Visit www.mainestandards.com or call 1-800-377-9684 for more information.
|
|
|
|
|
 |
|
The LIAISON® Treponema assay is your solution for automating syphilis testing. Improve sensitivity and specificity over RPR screening using our fully-automated LIAISON® XL platform. The LIAISON® Treponema assay detects both IgG and IgM antibody response to T. pallidum infections. Visit www.diasorin.com for more information.
|
|
|
|
Medical News Today
Alzheimer's disease is a progressive neurodegenerative disorder, thought to be caused by buildup of proteins in the brain. But there is increasing evidence that different biological processes are at the heart of the disease, providing scientists with a different approach to possible therapies.
READ MORE
HealthDay News
Researchers say they were able to coax tiny "seeds" of liver tissue into fully functioning livers in mice.
If this approach works in people, it could help reduce long wait lists for liver transplants. It might also benefit people with failing livers who don't quality for liver transplants, according to the researchers.
READ MORE
 |
|
• Because AMT-certified members are passionate and committed
to quality
• Because AMT combines robust eligibility requirements with a
rigorous exam to ensure that laboratory professionals are
well-prepared and competent
Find out more about why American Medical Technologists (AMT) is the excellent choice for your lab
|
|
The JAMA Network Journals via Medical Xpress
Genetic mutations in BRCA1 and BRCA2 increase the risk of breast and ovarian cancer in Ashkenazi Jewish women. A new article published by JAMA Oncology examines the likelihood of carrying another cancer-predisposing mutation in BRCA1, BRCA2 or another breast cancer gene among women of Ashkenazi Jewish ancestry with breast cancer who do not carry one of the founder mutations.
READ MORE
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
.gif)
